Fischer Medical Ventures shines as its arm further acquires shares of Sascan Meditech
Fischer Medical Ventures is currently trading at Rs. 801.00, up by 31.85 points or 4.14% from its previous closing of Rs. 769.15 on the BSE.
The scrip opened at Rs. 827.90 and has touched a high and low of Rs. 827.90 and Rs. 790.85 respectively. So far 507 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 919.00 on 28-Mar-2025 and a 52 week low of Rs. 454.35 on 02-May-2024.
Last one week high and low of the scrip stood at Rs. 867.95 and Rs. 747.15 respectively. The current market cap of the company is Rs. 5110.50 crore.
The promoters holding in the company stood at 74.91%, while Institutions and Non-Institutions held 6.75% and 18.33% respectively.
Fischer Medical Ventures’ Material Subsidiary -- Time Medical International Ventures (India) has further acquired 950 shares of Sascan Meditech consequent to the approval from the Board of Directors in their meeting held on July 10, 2024.
Objective of acquisition is for diversification and expansion of business. The company constantly explores various options for growing business and determined that this acquisition is in the best interest of the company. Cost of acquisition is Rs 2 crore constituting acquisition of 950 shares.
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
